Tandem Diabetes, a company that makes insulin pumps, had some bad news recently. Their sales predictions for the next few years were lower than experts expected. This made investors worried, and the price of their stock went down a lot!
- The company's sales were good for the last three months, but their prediction for the whole year was disappointing.
- Experts thought Tandem Diabetes would sell more insulin pumps.
- The price of Tandem Diabetes stock dropped sharply after the announcement.
| Fact | Number |
|---|---|
| Expected sales for 2025 | $997 million - $1.007 billion |
| Stock price drop | More than 32% |
| Sales in last three months | $252.4 million (adjusted) |
